A Pathological Microenvironment–Responsive Catalytic Carbon Nanodots Release Platform Intercepting the ROS–Inflammation Cascade to Alleviate Intervertebral Disc Degeneration
Advanced Healthcare Materials · 2026
DOI: 10.1002/adhm.71151 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Healthcare Materials, 2026. Verfasst von Xiang Luo und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopedics, The Second Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, Jiangxi, China. Hauptthemen laut MEDLINE: Reactive Oxygen Species, Intervertebral Disc Degeneration, Inflammation, Carbon. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 57 Literaturangaben. Gefördert von: National Natural Science Foundation of China, International Scientific and Technological Cooperation Project.
Abstract (Originalsprache)
Localized oxidative stress and chronic inflammation driven by excessive accumulation of reactive oxygen species (ROS) represent central pathogenic forces that initiate and perpetuate the degenerative cascade underlying intervertebral disc degeneration (IVDD). Here, it is developed a pathological microenvironment–responsive catalytic carbon nanodot delivery platform (PPOD@CeCDs) featuring dual reversible covalent cross‐linking mediated by phenylboronate ester and Schiff base bonds, which selectively senses the acidic and highly oxidative milieu characteristic of IVDD to enable on‐demand release of cerium‐doped carbon nanodots (CeCDs), thereby intercepting the ROS‐driven inflammatory cascade at its oxidative origin. PPOD@CeCDs exhibits favorable injectability, controllable degradability, biocompatibility, and robust antioxidant activity, together with stable intradiscal retention and stimulus‐responsive release under pathological conditions. In vitro, PPOD@CeCDs protects nucleus pulposus (NP) cells from oxidative injury, suppresses inflammation amplification by modulating the ROS‐driven PI3K–Akt–NF‐κB signaling axis, regulates macrophage polarization, and preserves extracellular matrix homeostasis. In a rat model of IVDD, intradiscal injection of PPOD@CeCDs mitigates matrix degradation and promotes structural restoration of degenerative discs. Collectively, by integrating a microenvironment‐responsive hydrogel with catalytically active carbon nanodots, this strategy sustainably intercepts ROS‐driven inflammatory cascades and offers a mechanistically defined, translationally promising therapeutic approach for IVDD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Orthopedics, The Second Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, Jiangxi, China.
- Jiangxi Provincial Key Laboratory of Spine and Spinal Cord Disease, Nanchang, Jiangxi, China.
- Jiangxi Medical College, Nanchang University, Nanchang, Jiangxi, China.
ORCID-Profile: Xinxin Miao
Förderung
- National Natural Science Foundation of China
- International Scientific and Technological Cooperation Project
Zitieren
APA
Luo, X., Xie, J., Yan, F., Peng, Z., Pan, C., Hu, Y., Zhang, J., Cai, C., Yuan, J., Li, Y., Miao, X., He, D., & Cheng, X. (2026). A Pathological Microenvironment–Responsive Catalytic Carbon Nanodots Release Platform Intercepting the ROS–Inflammation Cascade to Alleviate Intervertebral Disc Degeneration. Advanced Healthcare Materials. https://doi.org/10.1002/adhm.71151
Vancouver
Luo X, Xie J, Yan F, Peng Z, Pan C, Hu Y, et al. A Pathological Microenvironment–Responsive Catalytic Carbon Nanodots Release Platform Intercepting the ROS–Inflammation Cascade to Alleviate Intervertebral Disc Degeneration. Advanced Healthcare Materials. 2026. doi:10.1002/adhm.71151
BibTeX
@article{Luo2026,
author = {Luo, Xiang and Xie, Jiajun and Yan, Fengxu and Peng, Zhidong and Pan, Chongzhi and Hu, Yiming and Zhang, Jian and Cai, Changxiong and Yuan, Jinghong and Li, Yang and Miao, Xinxin and He, Dingwen and Cheng, Xigao},
title = {A Pathological Microenvironment–Responsive Catalytic Carbon Nanodots Release Platform Intercepting the ROS–Inflammation Cascade to Alleviate Intervertebral Disc Degeneration},
journal = {Advanced Healthcare Materials},
year = {2026},
doi = {10.1002/adhm.71151}
}
EUVIMED